Becton Dickinson & Co. recalls BD BBL Sensi Disc Tetracycline 30 ug
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
- Products
-
- BD BBL Sensi Disc Tetracycline 30 ug
- Company
- Becton Dickinson & Co.
- Where it was sold
-
Domestic distribution nationwide. International distribution worldwide.
Nationwide
- Barcodes
0038290230998730382902313442- Units affected
- 2,363,168 total units
- About this recall
- BD BBL Sensi Disc Tetracycline 30 ug,used for semi-quantitative in vitro susceptibility testing. Catalog Number 230998 and 231344¿